Showing results (81-90 of 199) with videos related to
Sort By:
Pageof 20
Urologic Oncology|June 27, 2009
Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removedIn Gab Jeong, Jinsung Park, Kanghyon Song, et al.Urology|October 10, 2012
Smoking and survival after radical cystectomy for bladder cancerChunwoo Lee, Kwang Hyun Kim, Dalsan You, et al.Journal of Cancer Research and Clinical Oncology|April 3, 2024
Association of preoperative sarcopenia with the long-term prognosis of patients with bladder cancer undergoing radical cystectomySangmin Lee, Youngjoon Yoon, Jungyo Suh, et al.Journal of Cancer Research and Clinical Oncology|June 23, 2019
Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette-Guérin immunotherapySung Jin Kim, Dalsan You, In Gab Jeong, et al.Clinical Genitourinary Cancer|May 27, 2015
Pulmonary Metastasectomy Could Prolong Overall Survival in Select Cases of Metastatic Urinary Tract CancerTaeeun Kim, Jin-Hee Ahn, Dalsan You, et al.The Journal of Urology|July 21, 2009
The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survivalJinsung Park, Seong Heon Ha, Gyeng Eun Min, et al.BJU International|September 22, 2011
Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsyMyungchan Park, Dalsan You, Jong Hyun Yoon, et al.Urologic Oncology|July 2, 2011
Tumor volume, surgical margin, and the risk of biochemical recurrence in men with organ-confined prostate cancerCheryn Song, Taejin Kang, Sangjun Yoo, et al.Japanese Journal of Clinical Oncology|October 25, 2014
Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy eraDalsan You, In Gab Jeong, Cheryn Song, et al.Cancer Chemotherapy and Pharmacology|May 24, 2015
Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinomaYi Rang Kim, Jae Lyun Lee, Dalsan You, et al.Pageof 20